Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.
------------------------------------------------------------
December 02, 2002
INTERNATIONAL IMMUNIZATION NEWS
"Chr Hansen's Grass Allergy Vaccine Ready for Phase IIb-III Clinical Trial" AFX-Europe (www.afxpress.com/corporate/AFX-Europe.htm) (11/27/02)
A Phase I-IIa trial of ALK-Abello's grass pollen allergy vaccine has shown the product to be safe and well tolerated. The subsidiary of Chr Hansen will conduct Phase IIb-III testing with Schering-Plough in multiple European nations and in Canada.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.